Update of Serratia marcescens bacteremia associated with contaminated magnesium sulfate

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Update of Serratia marcescens bacteremia associated with contaminated magnesium sulfate

Published Date:

4/8/05

Series:

HAN ; 226

Language:

English

[PDF-439.77 KB]

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Description:

Friday, April 08, 2005, 18:05 EDT (6:05 PM EDT)

CDCHAN-00226-2005-04-08-UPD-N

In follow-up to the previous notification of S. marcescens bacteremia associated with contaminated magnesium sulfate from PharMEDium (March 18, 2005), the Centers for Disease Control and Prevention (CDC) and Food and Drug Administration have obtained new information in their ongoing investigation. Because evidence exists to implicate at least three contaminated PharMEDium lots of magnesium sulfate, CDC recommends that magnesium sulfate solution from Pharmedium not be administered to patients until the scope of contamination can be determined. PharMEDium is voluntarily recalling all 50 ml. magnesium sulfate admixtures. These 50 ml preparations will not be available until further notice.

Subject:

[+]

Document Type:

HAN Health Update

Place as Subject:

United States

Collection(s):

Health Alert Network (HAN)

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Serratia marcescens blood stream infections associated with contaminated magnesium sulfate solutions - March 2005

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

3/18/05

Series:

HAN ; 224

Description:

Friday, March 18, 2005, 20:50 EDT (8:50 PM EDT)CDCHAN-00224-2005-03-18-ADV-NThe Centers for Disease Control and Prevention (CDC) has learned of 11 cases of Serratia marcescens (S. marcescens) bacteremia from two states associated with magnesium sulfa...

File Type:

[PDF - 688.68 KB]
Sphingomonaspaucimobilis Bloodstream Infections Associated with Contaminated Intravenous Fentanyl1

Personal Author:

Maragakis, Lisa L.; Chaiwarith, Romanee; Srinivasan, Arjun; Torriani, Francesca J.; Avdic, Edina; Lee, Andrew; Ross, Tracy R.; Carroll, Karen C.; Perl, Trish M.;

Published Date:

Jan 2009

Source:

Emerg Infect Dis. 15(1):12-18.

Description:

Nationally distributed medications from compounding pharmacies, which typically adhere to less stringent quality-control standards than pharmaceutical manufacturers, can lead to multistate outbreaks. We investigated a cluster of 6 patients in a Maryl...

File Type:

[PDF - 331.63 KB]
Laboratory replication of filtration procedures associated with Serratia marcescens bloodstream infections in patients receiving compounded amino acid solutions

Personal Author:

Moulton-Meissner, HeatHer; Noble-Wang, Judith; Gupta, Neil; Hocevar, Susan; Kallen, Alex; Arduino, Matthew;

Published Date:

Aug 01 2015

Source:

Am J Health Syst Pharm. 72(15):1285-1291

Description:

Purpose.Specific deviations from United States Pharmacopeia standards were analyzed to investigate the factors allowing an outbreak of Serratia marcescens bloodstream infections in patients receiving compounded amino acid solutions.Methods.Filter cha...

File Type:

[PDF - 588.46 KB]
Description of outbreaks of healthcare associated infections related to compounding pharmacies, 2000-2012

Personal Author:

Staes, Catherine; Jacobs, Jason; Mayer, Jeanmarie; Allen, Jill;

Published Date:

Aug 1 2013

Source:

Am J Health Syst Pharm. 70(15):1301-1312.

Description:

PurposeThe 2012 multistate fungal meningitis outbreak caused by contaminated methylprednisolone suggests that contaminated compounded drugs can pose a public health threat. The problem has not been well described. Our objective was to systematically ...

File Type:

[PDF - 504.62 KB]
Alcaligenes xylosoxidans Bloodstream Infections in Outpatient Oncology Office

Personal Author:

Kim, Moon J.; Bancroft, Elizabeth; Lehnkering, Eleanor; Donlan, Rodney M.; Mascola, Laurene;

Published Date:

Jul 2008

Source:

Emerg Infect Dis. 14(7):1046-1052.

Description:

Gaps in infection control led to biofilm production in central venous catheters and resultant bloodstream infection.|In 2002, we investigated a cluster of patients with | bloodstream infections by conducting a matched case–control study and a prosp...

File Type:

[PDF - 174.94 KB]